Italia markets closed

TEVA Mar 2025 12.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
5,69-0,01 (-0,18%)
In data: 10:00AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente5,70
Aperto5,69
Denaro5,95
Domanda6,10
Prezzo d'esercizio12,00
Scadenza2025-03-21
Min-Max giorno5,69 - 5,69
Contratto - Min-MaxN/D
Volume2
Open Interest488
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.